Related Experiment Video
Updated: May 19, 2026

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome
S Banka1, E Howard, S Bunstone
1Department of Genetic Medicine, St Mary's Hospital, Manchester Academic Health Sciences Centre (MAHSC), University of Manchester, Manchester, UK. Siddharth.Banka@manchester.ac.uk
Abstract:
Kabuki syndrome (KS) is a rare multi-system disorder that can result in a variety of congenital malformations, typical dysmorphism and variable learning disability. It is caused by MLL2 point mutations in the majority of the cases and, rarely by deletions involving KDM6A. Nearly one third of cases remain unsolved. Here, we expand the known genetic basis of KS by presenting five typical patients with the condition, all of whom have novel MLL2 mutation types- two patients with mosaic small deletions, one with a mosaic whole-gene deletion, one with a multi-exon deletion and one with an intragenic multi-exon duplication. We recommend MLL2 dosage studies for all patients with typical KS, where traditional Sanger sequencing fails to identify mutations. The prevalence of such MLL2 mutations in KS may be comparable with deletions involving KDM6A. These findings may be helpful in understanding the mutational mechanism of MLL2 and the disease mechanism of KS.
Insights
Kabuki syndrome (KS) is a rare genetic disorder. Researchers identified novel MLL2 gene mutations in five patients, expanding the known genetic causes of KS.
Area of Science:
- Genetics
- Molecular Biology
- Developmental Biology
Background:
- Kabuki syndrome (KS) is a rare genetic disorder characterized by congenital malformations, distinctive facial features, and developmental delays.
- Mutations in the MLL2 gene are the primary cause of KS, accounting for the majority of diagnosed cases.
- A significant portion of KS cases remain genetically unsolved, indicating the need for broader diagnostic approaches.
Observation:
- This study investigated five patients with clinically diagnosed Kabuki syndrome.
- All five patients presented with novel types of mutations within the MLL2 gene, including mosaic deletions and duplications.
- These mutations were not detectable through standard sequencing methods.
Findings:
- The study identified previously unreported MLL2 mutation types in Kabuki syndrome patients, including mosaic small deletions, whole-gene deletions, multi-exon deletions, and multi-exon duplications.
- These findings highlight the importance of considering MLL2 gene dosage abnormalities in KS diagnosis.
- The prevalence of these complex MLL2 mutations may be significant, potentially rivaling that of KDM6A deletions.
Implications:
- The discovery of novel MLL2 mutation types expands the genetic understanding of Kabuki syndrome.
- Recommending MLL2 dosage studies for unsolved KS cases can improve diagnostic yield.
- Further research into these MLL2 mutations will elucidate disease mechanisms and inform potential therapeutic strategies.
Related Concept Videos
Abnormal Proliferation
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
